Hi @joehick0529 — I’m not sure what N117 is, can you provide us with some context? I haven’t been as immersed in the research as I normally am (please forgive me if this is a dumb question) as I am trying to recover from a major exacerbation. I can see if there is anything I can find out about it for you though. Are you wanting a research paper on it? Char.
Ah, this is really great information, thanks for sending it. I don’t know too much about this but I am asking our team at BioNews if one of our science writers may be able to look into it for you a bit more. I haven’t followed up as to where it stands right now or obtained more information about it, but stay tuned and I’ll see if someone can get some feedback/content on it for you 🙂
Charlene.
Hi @joehick0529, I connected with our Editor-in-Chief here at BioNews and she let me know that a news column was published on N115 in August when the results of the study emerged. She also let me know that it doesn’t look like anymore information has been released since then, so a January press release from the company is misleading. Hopefully more results emerge soon! Here is the article: https://pulmonaryfibrosisnews.com/2019/08/19/n115-completes-trial-fda-marketing-application-pf-patients/
Hi @joehick0529 — I’m not sure what N117 is, can you provide us with some context? I haven’t been as immersed in the research as I normally am (please forgive me if this is a dumb question) as I am trying to recover from a major exacerbation. I can see if there is anything I can find out about it for you though. Are you wanting a research paper on it? Char.
Sorry the trial # is N115, and I have attached a link to what I have on it. Any info about this would be appreciated.
https://www.ptcommunity.com/wire/rx-globally-patented-non-steroidal-nasal-spray-all-lung-diseases-including-pulmonary-fibrosis
https://www.ptcommunity.com/wire/rx-globally-patented-non-steroidal-nasal-spray-all-lung-diseases-including-pulmonary-fibrosis
Another source for this.
https://www.prnewswire.com/news-releases/rx-globally-patented-non-steroidal-nasal-spray-for-all-lung-diseases-including-pulmonary-fibrosis-cf-copd-unmet-needs-with-no-known-side-effects-that-can-also-be-used-to-deliver-antivirals-antimicrobials-insulin-and-other-dr-300986730.html
Hi @joehick0529,
Ah, this is really great information, thanks for sending it. I don’t know too much about this but I am asking our team at BioNews if one of our science writers may be able to look into it for you a bit more. I haven’t followed up as to where it stands right now or obtained more information about it, but stay tuned and I’ll see if someone can get some feedback/content on it for you 🙂
Charlene.
Thanks. Will look forward to any info on what seems to be a promising drug.
Hi @joehick0529, I connected with our Editor-in-Chief here at BioNews and she let me know that a news column was published on N115 in August when the results of the study emerged. She also let me know that it doesn’t look like anymore information has been released since then, so a January press release from the company is misleading. Hopefully more results emerge soon! Here is the article: https://pulmonaryfibrosisnews.com/2019/08/19/n115-completes-trial-fda-marketing-application-pf-patients/
Warmly,
Charlene.
Thank you. Look forward to any news on this research.